Skip to content

Study · Not a test of the peptide alone · 1998

1 result

Venous ulcers: improved healing by iontophoretic administration of calcitonin gene-related peptide and vasoactive intestinal polypeptide.

Gherardini G, Gürlek A, Evans GR, Milner SM, Matarasso A, Wassler M, Jernbeck J, Lundeberg T

Plastic and reconstructive surgery1 Jan 1998Cited by 15 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Vasoactive intestinal peptide (VIP, aviptadil) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Vasoactive intestinal peptide (VIP, aviptadil).

  1. 01HumanNot a test of Vasoactive intestinal peptide (VIP, aviptadil) aloneRandomized controlled trialEfficacy outcome

    In 66 patients with venous stasis ulcers, iontophoresis of CGRP plus VIP with standard treatment significantly improved healing compared with standard treatment plus placebo iontophoresis.

    In plain wordsIn people with venous leg ulcers, CGRP and VIP given by iontophoresis improved healing more than placebo iontophoresis. Both groups also had standard treatment.

    Outcome
    IncreaseVenous ulcer healing
    Study

    n = 66

    Comparator
    Standard treatment plus placebo iontophoresis
    Outcome group
    Wound healing · Skin and wound

    Source sentences

    Summary
    there were significant improvements of the healing process in the group treated with calcitonin gene-related peptide and vasoactive intestinal polypeptide when compared with placebo iontophoresis
    2 context sentences
    Summary · context
    Two randomized groups of patients were compared, one receiving standard treatment plus iontophoresis of calcitonin gene-related peptide and vasoactive intestinal polypeptide, and the other receiving standard treatment plus placebo iontophoresis.
    Summary · context
    Calcitonin gene-related peptide and vasoactive intestinal polypeptide were administered locally by iontophoresis for 20 min three times weekly for 12 weeks.

    In this study, Vasoactive intestinal peptide (VIP, aviptadil) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Vasoactive intestinal peptide (VIP, aviptadil).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    9 Oct 2026, 19:08 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.